Description
Desmethyl VS5584 Is an intermediate in the synthesis of purine analogs and potential tyrosine kinase inhibitor. This analog is a highly selective PI3K/mTOR kinase inhibitor.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Desmethyl VS5584 Is an intermediate in the synthesis of purine analogs and potential tyrosine kinase inhibitor. This analog is a highly selective PI3K/mTOR kinase inhibitor.
| Cas No. | 1246535-95-4 |
|---|---|
| Purity | ≥98% |
| Formula | C16H20N8O |
| Formula Wt. | 340.39 |
| IUPAC Name | 5-[9-Isopropyl-2-(4-morpholinyl)-9H-purin-6-yl]-2-pyrimidinamine |
| Synonym | Desmethyl-VS-5584, Desmethyl VS5584, Desmethyl VS 5584, VS-5584 Analog |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Zhou C, Li X, He A, et al. Development of a UPLC-MS/MS method for the quantification of VS-5584 and its application in pharmacokinetic studies in rats. J Anal Methods Chem. 2020 Dec 16;2020:8811522. PMID: 33381351.
Chen Y, Tsai H, Tsai Y, et al. VS-5584, a PI3K/mTOR dual inhibitor, exerts antitumor effects on neuroblastomas in vitro and in vivo. J Pediatr Surg. 2021 Aug;56(8):1441-1448. PMID: 33189297.
Xu M, Xu L, Wang Y, et al. BRD4 inhibition sensitizes renal cell carcinoma cells to the PI3K/mTOR dual inhibitor VS-5584. Aging (Albany NY). 2020 Oct 13;12(19):19147-19158. PMID: 33051401.
V2 antagonist.
NSAID; COX-2 inhibitor.
Mycotoxin that has structural similarity to est...
Imidazoline and α2-adrenergic agonist, Nav1.7 ...
Synthetic ITC.
PI3K and HDAC inhibitor.
Endogenous peptide hormone, involved in secreti...
Inhibitor of EGFR.
Immunomodulator; teratogen.
Reduces production of thyroid hormones
RIP1 inhibitor.
PPARγ coactivator-1α expression stimulator.
Nucleoside (deoxyuridine) analog; DNA chain ter...
Glycosaminoglycan
Dopamine reuptake inhibitor (DRI).
Fluoroquinolone; bacterial DNA gyrase inhibitor...
Found in Paeonia; L-type Ca2+ channel blocker.<...
Vitamin E analog, antioxidant.
Synthesis impurity
Tricyclic antidepressant; potential D1/2 antago...